Vigabatrin For Solution
Product Images NDC 60219-1425

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 60219-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Vigabatrin For Oral Solution Usp 500 mg 1)

Chemical structure diagram of Vigabatrin, showing its molecular arrangement with an amino group, double bond, and carboxylic acid group.*

FDA Label Image

7 (Vigabatrin For Oral Solution Usp 500 mg 10)

An instructional illustration showing a hand holding an oral dosing syringe filled with liquid medication up to the 10 mL marking. A label points to the 10 mL line on the syringe, indicating measurement accuracy for dosing.*

FDA Label Image

8 (Vigabatrin For Oral Solution Usp 500 mg 11)

An instructional illustration showing a gloved hand using a syringe to measure or transfer liquid into a clear empty glass. The image is labeled as Figure F.*

FDA Label Image

9 (Vigabatrin For Oral Solution Usp 500 mg 12)

An image showing a hand holding a spoon partially submerged in a clear glass of liquid. The image appears to be instructional, likely demonstrating the method of use or administration related to an oral solution product.*

FDA Label Image

10 (Vigabatrin For Oral Solution Usp 500 mg 13)

An instructional image labeled 'Figure H' showing a hand holding a dosing syringe being inserted into a glass, likely demonstrating preparation or administration of an oral solution.*

FDA Label Image

11 (Vigabatrin For Oral Solution Usp 500 mg 14)

An instructional illustration showing a hand holding a clear oral dosing syringe with measured volume markings. The syringe is designed for dispensing an oral solution accurately.*

FDA Label Image

12 (Vigabatrin For Oral Solution Usp 500 mg 15)

An illustration labeled 'Figure J' showing a young child sitting cross-legged on a surface, receiving oral medication from a syringe held by an adult hand. The child is wearing a light-colored polo shirt and looking at the syringe.*

FDA Label Image

1 (Vigabatrin For Oral Solution Usp 500 mg 16)

Vigabatrin 500 mg/1 oral solution packet label by Amneal Pharmaceuticals NY LLC. The label includes NDC 60219-1425-1, dosing instructions to mix each packet with 10 mL of water, and directions to immediately administer the directed amount and discard unused portion. Storage instructions specify 20° to 25°C room temperature. Manufactured in India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Barcode and lot/expiration placeholders are also visible.*

FDA Label Image

2 (Vigabatrin For Oral Solution Usp 500 mg 17)

The packaging label for Vigabatrin for Oral Solution, USP, 500 mg per packet, by Amneal Pharmaceuticals NY LLC. The label displays the dosage form as oral solution, with 50 packets in the package. Directions for use instruct mixing each packet with 10 mL of water before administration. Manufacturing and distribution information is provided, including sites in India and New Jersey.*

FDA Label Image

1 (Vigabatrin For Oral Solution Usp 500 mg 2)

A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' showing the relationship between the percentage of patients and percent reduction in seizure frequency. The graph compares three dosing groups of Vigabatrin (1g/day, 3g/day, and 6g/day) against placebo, illustrating the improvement or worsening in seizure frequency across patient percentages.*

FDA Label Image

2 (Vigabatrin For Oral Solution Usp 500 mg 3)

A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' showing the percentage of patients on the x-axis (100% to 0%) versus percent reduction in seizure frequency on the y-axis (-100% to 100%). Two curves compare seizure frequency changes for patients on placebo versus those receiving 3g/day Vigabatrin (VGB). The y-axis indicates improvement above zero and worsening below zero, illustrating treatment effects over the patient population.*

FDA Label Image

1 (Vigabatrin For Oral Solution Usp 500 mg 4)

Vigabatrin 500 mg/1 oral solution in a clear glass with a label indicating the product name and details. Also shown are two oral syringes, an empty glass with a spoon inside, and a pair of scissors placed beside the glass containing the solution.*

FDA Label Image

2 (Vigabatrin For Oral Solution Usp 500 mg 5)

An instructional diagram of a syringe showing labeled parts including the tip, dosage indicators, barrel, bottom of white plunger, and plunger. It provides a visual guide for identifying key components of the syringe used for oral administration.*

FDA Label Image

3 (Vigabatrin For Oral Solution Usp 500 mg 6)

Figure A shows a hand pouring the contents of a small packet labeled for Vigabatrin oral solution into a clear glass, illustrating preparation for administration.*

FDA Label Image

4 (Vigabatrin For Oral Solution Usp 500 mg 7)

An illustration showing two clear drinking glasses side by side; the left glass is partially filled with a liquid, while the right glass is empty. The figure is labeled as Figure B.*

FDA Label Image

5 (Vigabatrin For Oral Solution Usp 500 mg 8)

An instructional photograph labeled 'Figure C' showing a hand holding a syringe submerged in a clear glass of water, likely illustrating how to prepare an oral solution dose of Vigabatrin 500 mg/1 for administration.*

FDA Label Image

6 (Vigabatrin For Oral Solution Usp 500 mg 9)

An instructional illustration showing a hand holding an oral dosing syringe filled with liquid medication. The syringe is marked with volume measurements in milliliters for precise dosing, typically used for administering Vigabatrin oral solution, 500 mg/1 mL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.